21 U.S.C. § 350a — Infant formulas
submitted 88 years ago by Pub. L. 96-359 to r/title-21-FOOD-AND-DRUGS · 3,107 words · no verdicts yet
Infant formula makers must meet nutrient, quality, and manufacturing rules the Secretary sets, and test each batch before selling it. New formulas must be registered and reviewed before they reach the market, and makers must promptly report safety problems and recall unsafe formula. Makers must also keep detailed records, and the Secretary can waive certain rules to prevent or ease a formula shortage.
(a) Adulteration: An infant formula*, including infant formula powder, is deemed adulterated if (1) it does not provide the nutrients required by subsection (i), (2) it does not meet the quality factor requirements the Secretary* prescribed under subsection (b)(1), or (3) it was not processed in compliance with the good manufacturing practices and quality control procedures the Secretary prescribed under subsection (b)(2).
(b) Requirements for quality factors, good manufacturing practices, and retention of records: (1) The Secretary must, by regulation, establish quality factor requirements for infant formulas, as consistent as possible with current scientific knowledge, including for the nutrients required by subsection (i). (2)(A) The Secretary must, by regulation, establish good manufacturing practices, including quality control procedures needed to ensure a formula provides the required nutrients and is manufactured to prevent adulteration. (B) These practices must include requirements for: (i) testing, following paragraph (3), of each batch for each nutrient required by subsection (i) before distribution; (ii) regularly scheduled testing of formula samples throughout their shelf life; (iii) in-process controls, including testing where necessary, to prevent adulteration of each batch; and (iv) regularly scheduled audits, by people with no direct responsibility for manufacturing the formula, confirming compliance with the good manufacturing practice regulations. (3) Testing requirements: (A) At the "final product stage" — the point before distribution where the formula is homogenous and no longer subject to further degradation — each batch must be tested for vitamins A, B1, C, and E. (B) Each nutrient premix used must be tested for each required nutrient it contains, confirming compliance with its specifications or supplier certification. (C) During manufacturing or at the final product stage, and before distribution, the formula must be tested for any other required nutrients not already tested under (A) or (B), to confirm the batch complies and that nutrients from any premix reached the proper concentration. (D) If the Secretary adds a nutrient to the table in subsection (i), the Secretary must require testing for that new nutrient under (A), (B), or (C). (4)(A) The Secretary must, by regulation, establish recordkeeping requirements covering: (i) all records demonstrating compliance with the manufacturing and quality control rules, including test results; (ii) all premix supplier certifications and guarantees of analysis; (iii) records confirming the accuracy of those certifications; (iv) records on the microbiological quality of raw materials and finished formula, and records showing that packaging materials do not cause adulteration; (v) records of audit results; and (vi) all complaints, plus files reviewing complaints that might reveal a health hazard. (B) These records must be kept for at least one year past the formula's shelf life and made available to the Secretary on request, except that for the audits required by (2)(B)(iv), the manufacturer need only give the Secretary written assurance the audits are being conducted, not the actual audit reports.
(c) Registration of persons distributing new infant formula: (1) No one may introduce a "new infant formula" into interstate commerce* unless they have registered their name, business location, and manufacturing sites with the Secretary beforehand, and made the submission required by subsection (d)(1) at least 90 days before marketing it. (2) "New infant formula" includes a formula made by a manufacturer that has not previously made infant formula, and a formula with a "major change" in processing or formulation from a manufacturer's current or prior product — using the meaning of "major change" in the FDA's regulations as they existed on August 1, 1986.
(d) Submission of information about new infant formula required: (1) The required submission must include the formula's exact quantitative recipe, a description of any reformulation or processing change, assurances the formula will meet subsections (b)(1) and (i) as shown by the testing required under (b)(3), and assurances that processing complies with (b)(2). (2) After first producing a covered formula, and before shipping it, the manufacturer must send the Secretary a written verification summarizing test results and records showing compliance with several listed subsections. (3) If a manufacturer determines a formulation or processing change may affect whether a formula becomes adulterated under subsection (a), it must make the submission required by paragraph (1) before first processing the changed formula. (4) The Secretary must respond to a submission within 45 days of receiving it.
(e) Additional notice requirements for manufacturer: (1) If a manufacturer has knowledge reasonably supporting that formula which already left the manufacturer's control may not provide the required nutrients, or may be otherwise adulterated or misbranded, the manufacturer must promptly notify the Secretary. If the Secretary determines the formula presents a risk to human health, the manufacturer must immediately recall it from all wholesale and retail establishments, following the Secretary's recall regulations. (2) "Knowledge" for this purpose means either actual knowledge, or the knowledge a reasonable person* would have had under similar circumstances, or would have obtained through due care.
(f) Procedures applicable to recalls by manufacturer; regulatory oversight: (1) If a manufacturer begins a recall, it must follow requirements the Secretary prescribes under paragraph (2), and: (A) the Secretary must review the recall's progress within 15 days of it starting, and at least every 15 days after, to check compliance; (B) the manufacturer must report its recall actions to the Secretary within 14 days of starting, and at least every 14 days after, until the recall ends. (2) The Secretary must prescribe, by regulation, the scope and extent recalls must have based on the degree of health risk. (3) The Secretary must require manufacturers doing a health-risk recall to ask retailers to post a recall notice at the point of purchase, for as long as the Secretary determines is needed to inform the public.
(g) Recordkeeping requirements for manufacturer; regulatory oversight and enforcement: (1) Each manufacturer must keep records of how it distributed formula through facilities it owns or operates, sufficient to carry out and monitor recalls. These records must be retained for at least one year past the formula's shelf life. (2) If the Secretary determines these records are not being properly made or kept, the Secretary may, by regulation, prescribe the required records and retention rules — but any such regulation cannot take effect sooner than 180 days after being issued, and applies only to formula distributed after that effective date.
(h) Exemptions; regulatory oversight: (1) A formula represented and labeled for infants with an inborn error of metabolism, low birth weight, or another unusual medical or dietary problem is exempt from subsections (a), (b), and (c). Its manufacturer must still give the notice required by (e)(1) — but only regarding adulteration or misbranding described in (e)(1)(B) — and must comply with the regulations the Secretary prescribes under paragraph (2). (2) The Secretary may, by regulation, set the terms and conditions for this exemption, and may withdraw it for a formula that stops complying with those terms.
(i) Nutrient requirements: (1) Infant formula must contain nutrients matching the table in this subsection, which the Secretary reviews about every four years, considering new scientific data and international infant formula standards. The Secretary may revise the list of required nutrients and the required level for any nutrient. (2) The Secretary may, by regulation, revise the list of nutrients in the table, and revise the required level for any listed nutrient. The statute's nutrient table sets a minimum and, for some nutrients, a maximum amount per 100 kilocalories for: protein; fat (both grams and percent of calories); essential fatty acids (linoleate); vitamins A, D, K, E, C, B1, B2, B6, B12, niacin, folic acid, pantothenic acid, biotin, choline, and inositol; and the minerals calcium, phosphorus, magnesium, iron, iodine, zinc, copper, manganese, sodium, potassium, and chloride. Footnotes to the table add extra rules: protein must be at least as nutritionally useful as casein; biotin, choline, and inositol amounts apply only to formulas that are not milk-based; and the ratio of calcium to phosphorus must stay between 1.1 and 2.0.
(j) Premarket submissions to address shortages: (1) The Secretary must waive the normal 90-day premarket submission requirement under subsection (c) and instead apply a 30-day requirement for anyone introducing a new infant formula. (2) This shorter waiver period lasts 90 days from when the Secretary distributes information under section 350m(a)(2) about a formula shortage, or longer if the Secretary determines that is appropriate to prevent or ease a shortage.
(k) Congressional notification of recall: (1) Within 24 hours of starting a formula recall described in subsection (e), the Secretary must notify the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce. (2) That notification must include: (A) if the FDA required the recall, a summary of the information supporting the finding that the formula risks human health; (B) if the manufacturer began the recall voluntarily, a summary of the information the manufacturer gave the FDA about formula that left its control and may be adulterated or misbranded; (C) when the FDA was first made aware of the situation; and (D) an initial estimate of the disruption to domestic production the recall may cause.
(l) Annual report to Congress: (1) By March 30 each year, the Secretary must report to Congress on the preceding calendar year, covering: (A) the number of submissions received under subsection (d); (B) how many of those submissions included new ingredients not already in any formula on the market; (C) the number of FDA inspections conducted to check compliance with subsection (b); (D) the time between such inspections and any needed reinspection; and (E) a breakdown of items (A) through (D) between foreign and domestic manufacturers and facilities. (2) The Secretary must ensure these reports do not include trade secrets or other confidential information protected under section 552(b)(4) of title 5 or section 1905 of title 18.
(m) Waiver of requirements for importation of specialty infant formula: (1) During a shortage of specialty infant formula, as the Secretary determines, the Secretary may waive requirements under this chapter to help import specialty infant formula — either (A) from a country the Secretary determines enforces infant formula rules that give safety and nutritional assurances similar to this chapter's, or (B) for the distribution and sale of that imported specialty infant formula. (2) This waiver does not limit the Secretary's authority to still require a recall of, or otherwise impose restrictions on, specialty infant formula covered by a waiver. (3) "Specialty infant formula" means the formula described in subsection (h)(1) — formula for infants with unusual medical or dietary needs.
An infant formula*, including an infant formula powder, shall be deemed to be adulterated if—
such infant formula does not provide nutrients as required by subsection (i),
such infant formula does not meet the quality factor requirements prescribed by the Secretary* under subsection (b)(1), or
the processing of such infant formula is not in compliance with the good manufacturing practices and the quality control procedures prescribed by the Secretary under subsection (b)(2).
The Secretary shall by regulation establish requirements for quality factors for infant formulas to the extent possible consistent with current scientific knowledge, including quality factor requirements for the nutrients required by subsection (i).
The Secretary shall by regulation establish good manufacturing practices for infant formulas, including quality control procedures that the Secretary determines are necessary to assure that an infant formula provides nutrients in accordance with this subsection and subsection (i) and is manufactured in a manner designed to prevent adulteration of the infant formula.
The good manufacturing practices and quality control procedures prescribed by the Secretary under subparagraph (A) shall include requirements for—
the testing, in accordance with paragraph (3) and by the manufacturer of an infant formula or an agent of such manufacturer, of each batch of infant formula for each nutrient required by subsection (i) before the distribution of such batch,
regularly scheduled testing, by the manufacturer of an infant formula or an agent of such manufacturer, of samples of infant formulas during the shelf life of such formulas to ensure that such formulas are in compliance with this section,
in-process controls including, where necessary, testing required by good manufacturing practices designed to prevent adulteration of each batch of infant formula, and
the conduct by the manufacturer of an infant formula or an agent of such manufacturer of regularly scheduled audits to determine that such manufacturer has complied with the regulations prescribed under subparagraph (A).
In prescribing requirements for audits under clause (iv), the Secretary shall provide that such audits be conducted by appropriately trained individuals who do not have any direct responsibility for the manufacture or production of infant formula.
At the final product stage, each batch of infant formula shall be tested for vitamin A, vitamin B1, vitamin C, and vitamin E to ensure that such infant formula is in compliance with the requirements of this subsection and subsection (i) relating to such vitamins.
Each nutrient premix used in the manufacture of an infant formula shall be tested for each relied upon nutrient required by subsection (i) which is contained in such premix to ensure that such premix is in compliance with its specifications or certifications by a premix supplier.
During the manufacturing process or at the final product stage and before distribution of an infant formula, an infant formula shall be tested for all nutrients required to be included in such formula by subsection (i) for which testing has not been conducted pursuant to subparagraph (A) or (B). Testing under this subparagraph shall be conducted to—
ensure that each batch of such infant formula is in compliance with the requirements of subsection (i) relating to such nutrients, and
confirm that nutrients contained in any nutrient premix used in such infant formula are present in each batch of such infant formula in the proper concentration.
If the Secretary adds a nutrient to the list of nutrients in the table in subsection (i), the Secretary shall by regulation require that the manufacturer of an infant formula test each batch of such formula for such new nutrient in accordance with subparagraph (A), (B), or (C).
For purposes of this paragraph, the term “final product stage” means the point in the manufacturing process, before distribution of an infant formula, at which an infant formula is homogenous and is not subject to further degradation.
The Secretary shall by regulation establish requirements respecting the retention of records. Such requirements shall provide for—
the retention of all records necessary to demonstrate compliance with the good manufacturing practices and quality control procedures prescribed by the Secretary under paragraph (2), including records containing the results of all testing required under paragraph (2)(B),
the retention of all certifications or guarantees of analysis by premix suppliers,
the retention by a premix supplier of all records necessary to confirm the accuracy of all premix certifications and guarantees of analysis,
the retention of—
all records pertaining to the microbiological quality and purity of raw materials used in infant formula powder and in finished infant formula, and
all records pertaining to food* packaging materials which show that such materials do not cause an infant formula to be adulterated within the meaning of section 342(a)(2)(C) of this title,
the retention of all records of the results of regularly scheduled audits conducted pursuant to the requirements prescribed by the Secretary under paragraph (2)(B)(iv), and
the retention of all complaints and the maintenance of files with respect to, and the review of, complaints concerning infant formulas which may reveal the possible existence of a hazard to health.
Records required under subparagraph (A) with respect to an infant formula shall be retained for at least one year after the expiration of the shelf life of such infant formula. Except as provided in clause (ii), such records shall be made available to the Secretary for review and duplication upon request of the Secretary.
A manufacturer need only provide written assurances to the Secretary that the regularly scheduled audits required by paragraph (2)(B)(iv) are being conducted by the manufacturer, and need not make available to the Secretary the actual written reports of such audits.
No person* shall introduce or deliver for introduction into interstate commerce* any new infant formula unless—
such person has, before introducing such new infant formula, or delivering such new infant formula for introduction, into interstate commerce, registered with the Secretary the name of such person, the place of business of such person, and all establishments at which such person intends to manufacture such new infant formula, and
such person has at least 90 days before marketing such new infant formula, made the submission to the Secretary required by subsection (d)(1).
For purposes of paragraph (1), the term “new infant formula” includes—
an infant formula manufactured by a person which has not previously manufactured an infant formula, and
an infant formula manufactured by a person which has previously manufactured infant formula and in which there is a major change, in processing or formulation, from a current or any previous formulation produced by such manufacturer.
For purposes of this paragraph, the term “major change” has the meaning given to such term in section 106.30(c)(2) of title 21, Code of Federal Regulations (as in effect on August 1, 1986), and guidelines issued thereunder.
A person shall, with respect to any infant formula subject to subsection (c), make a submission to the Secretary which shall include—
the quantitative formulation of the infant formula,
a description of any reformulation of the formula or change in processing of the infant formula,
assurances that the infant formula will not be marketed unless it meets the requirements of subsections (b)(1) and (i), as demonstrated by the testing required under subsection (b)(3), and
assurances that the processing of the infant formula complies with subsection (b)(2).
After the first production of an infant formula subject to subsection (c), and before the introduction into interstate commerce of such formula, the manufacturer of such formula shall submit to the Secretary, in such form as may be prescribed by the Secretary, a written verification which summarizes test results and records demonstrating that such formula complies with the requirements of subsections (b)(1), (b)(2)(A), (b)(2)(B)(i), (b)(2)(B)(iii), (b)(3)(A), (b)(3)(C), and (i).
If the manufacturer of an infant formula for commercial or charitable distribution for human consumption determines that a change in the formulation of the formula or a change in the processing of the formula may affect whether the formula is adulterated under subsection (a), the manufacturer shall, before the first processing of such formula, make the submission to the Secretary required by paragraph (1).
The Secretary shall provide a response to a submission under this subsection not later than 45 days after receiving such submission.
If the manufacturer of an infant formula has knowledge which reasonably supports the conclusion that an infant formula which has been processed by the manufacturer and which has left an establishment subject to the control of the manufacturer—
may not provide the nutrients required by subsection (i), or
may be otherwise adulterated or misbranded,
the manufacturer shall promptly notify the Secretary of such knowledge. If the Secretary determines that the infant formula presents a risk to human health, the manufacturer shall immediately take all actions necessary to recall shipments of such infant formula from all wholesale and retail establishments, consistent with recall regulations and guidelines issued by the Secretary.
For purposes of paragraph (1), the term “knowledge” as applied to a manufacturer means (A) the actual knowledge that the manufacturer had, or (B) the knowledge which a reasonable person would have had under like circumstances or which would have been obtained upon the exercise of due care.
If a recall of infant formula is begun by a manufacturer, the recall shall be carried out in accordance with such requirements as the Secretary shall prescribe under paragraph (2) and—
the Secretary shall, not later than the 15th day after the beginning of such recall and at least once every 15 days thereafter until the recall is terminated, review the actions taken under the recall to determine whether the recall meets the requirements prescribed under paragraph (2), and
the manufacturer shall, not later than the 14th day after the beginning of such recall and at least once every 14 days thereafter until the recall is terminated, report to the Secretary the actions taken to implement the recall.
The Secretary shall by regulation prescribe the scope and extent of recalls of infant formulas necessary and appropriate for the degree of risks to human health presented by the formula subject to the recall.
The Secretary shall by regulation require each manufacturer of an infant formula who begins a recall of such formula because of a risk to human health to request each retail establishment at which such formula is sold or available for sale to post at the point of purchase of such formula a notice of such recall at such establishment for such time that the Secretary determines necessary to inform the public of such recall.
Each manufacturer of an infant formula shall make and retain such records respecting the distribution of the infant formula through any establishment owned or operated by such manufacturer as may be necessary to effect and monitor recalls of the formula. Such records shall be retained for at least one year after the expiration of the shelf life of the infant formula.
To the extent that the Secretary determines that records are not being made or maintained in accordance with paragraph (1), the Secretary may by regulation prescribe the records required to be made under paragraph (1) and requirements respecting the retention of such records under such paragraph. Such regulations shall take effect on such date as the Secretary prescribes but not sooner than the 180th day after the date such regulations are promulgated. Such regulations shall apply only with respect to distributions of infant formulas made after such effective date.
Any infant formula which is represented and labeled for use by an infant—
who has an inborn error of metabolism or a low birth weight, or
who otherwise has an unusual medical or dietary problem,
is exempt from the requirements of subsections (a), (b), and (c). The manufacturer of an infant formula exempt under this paragraph shall, in the case of the exempt formula, be required to provide the notice required by subsection (e)(1) only with respect to adulteration or misbranding described in subsection (e)(1)(B) and to comply with the regulations prescribed by the Secretary under paragraph (2).
The Secretary may by regulation establish terms and conditions for the exemption of an infant formula from the requirements of subsections (a), (b), and (c). An exemption of an infant formula under paragraph (1) may be withdrawn by the Secretary if such formula is not in compliance with applicable terms and conditions prescribed under this paragraph.
An infant formula shall contain nutrients in accordance with the table set out in this subsection, which shall be reviewed by the Secretary every 4 years as appropriate. In reviewing such table, the Secretary shall consider any new scientific data or information related to infant formula nutrients, including international infant formula standards. The Secretary may revise the list of nutrients and the required level for any nutrient required by the table.
The Secretary may by regulation—
revise the list of nutrients in the table in this subsection, and
revise the required level for any nutrient required by the table.
NUTRIENTS | |||
|---|---|---|---|
Nutrient | Minimum a | Maximum a | |
a Stated per 100 kilocalories. | |||
b The source of protein shall be at least nutritionally equivalent to casein. | |||
c Retinol equivalents. | |||
d Required to be included in this amount only in formulas which are not milk-based. | |||
e Calcium to phosphorus ratio must be no less than 1.1 nor more than 2.0. | |||
Protein (gm) | 1.8 b | 4.5. | |
Fat: | |||
gm | 3.3 | 6.0. | |
percent cal | 30.0 | 54.0. | |
Essential fatty acids (linoleate): | |||
percent cal | 2.7 | ||
mg | 300.0 | ||
Vitamins: | |||
A (IU) | 250.0 | (75 μg)c | 750.0 (225 μg).c |
D (IU) | 40.0 | 100.0. | |
K (μg) | 4.0 | ||
E (IU) | 0.7 | (with 0.7 IU/gm linoleic acid) | |
C (ascorbic acid) (mg) | 8.0 | ||
B1 (thiamine) (μg) | 40.0 | ||
B2 (riboflavin) (μg) | 60.0 | ||
B6 (pyridoxine) (μg) | 35.0 | (with 15 μg/gm of protein in formula) | |
B12 (μg) | 0.15 | ||
Niacin (μg) | 250.0 | ||
Folic acid (μg) | 4.0 | ||
Pantothenic acid (μg) | 300.0 | ||
Biotin (μg) | 1.5 d | ||
Choline (mg) | 7.0 d | ||
Inositol (mg) | 4.0 d | ||
Minerals: | |||
Calcium (mg) | 50.0 e | ||
Phosphorus (mg) | 25.0 e | ||
Magnesium (mg) | 6.0 | ||
Iron (mg) | 0.15 | ||
Iodine (μg) | 5.0 | ||
Zinc (mg) | 0.5 | ||
Copper (μg) | 60.0 | ||
Manganese (μg) | 5.0 | ||
Sodium (mg) | 20.0 | 60.0. | |
Potassium (mg) | 80.0 | 200.0. | |
Chloride (mg) | 55.0 | 150.0. |
The Secretary shall waive the 90-day premarket submission requirement under subsection (c) and apply a 30-day premarket submission requirement for any person who intends to introduce or deliver for introduction into interstate commerce any new infant formula.
The waiver authority under this subsection shall remain in effect—
for 90 days beginning on the date that the Secretary distributes information under section 350m(a)(2) of this title with respect to a shortage of infant formula; or
such longer period as the Secretary determines appropriate, to prevent or mitigate a shortage of infant formula.
Not later than 24 hours after the initiation of a recall of infant formula as described in subsection (e), the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a notification of such recall.
A notification under paragraph (1) shall include the following:
If the recall is required by the Food and Drug* Administration, a summary of the information supporting a determination that the adulterated or misbranded infant formula presents a risk to human health.
If the recall is voluntarily initiated by the manufacturer, a summary of the information provided to the Food and Drug Administration by the manufacturer regarding infant formula that has left the control of the manufacturer that may be adulterated or misbranded.
Specification of when the Food and Drug Administration was first made aware of the instance or circumstances surrounding the recall.
An initial estimate of the disruption in domestic production that may result from the recall.
Not later than March 30 of each year, the Secretary shall submit a report to Congress containing, with respect to the preceding calendar year, the following information:
The number of submissions received by the Secretary under subsection (d).
The number of such submissions that included any new ingredients that were not included in any infant formula already on the market.
The number of inspections conducted by the Food and Drug Administration or any agent thereof to evaluate compliance with the requirements for infant formulas under subsection (b).
The time between any inspection referred to in subparagraph (C) and any necessary reinspection to evaluate compliance with the requirements for infant formulas under subsection (b).
A breakdown of the information described in subparagraphs (A) through (D) between foreign and domestic manufacturers and facilities.
The Secretary shall ensure that the reports under paragraph (1) do not include any information that is a trade secret or confidential information subject to section 552(b)(4) of title 5 or section 1905 of title 18.
The Secretary may, during a shortage of specialty infant formula as determined by the Secretary, waive any requirement under this chapter applicable to facilitate the importation of specialty infant formula. Such a waiver may be applicable to—
the importation of specialty infant formula from any country that is determined by the Secretary to be implementing and enforcing requirements for infant formula that provide a similar assurance of safety and nutritional adequacy as the requirements of this chapter; or
the distribution and sale of such imported specialty infant formula.
Nothing in paragraph (1) shall be construed to limit the authority of the Secretary to require a recall of, or otherwise impose restrictions and requirements under this chapter with respect to, specialty infant formula that is subject to a waiver under paragraph (1).
In this subsection, the term “specialty infant formula” means infant formula described in subsection (h)(1).
Source credit: (June 25, 1938, ch. 675, § 412, as added Pub. L. 96–359, § 2, Sept. 26, 1980, 94 Stat. 1190; amended Pub. L. 99–570, title IV, § 4014(a), (b)(1), Oct. 27, 1986, 100 Stat. 3207–116, 3207–120; Pub. L. 103–80, § 3(l), Aug. 13, 1993, 107 Stat. 777; Pub. L. 117–328, div. FF, title III, § 3401(c), (g)(1)–(4), (6), (l), Dec. 29, 2022, 136 Stat. 5838, 5840, 5841, 5845.)
- 1938Enacted · Pub. L. 96-359 · 94 Stat. 1190
- 1986Amended · Pub. L. 99-570 · 100 Stat. 3207
- 1993Amended · Pub. L. 103-80 · 107 Stat. 777
- 2022Amended · Pub. L. 117-328 · 136 Stat. 5838, 5840, 5841, 5845
A history note hasn’t been published yet. The record shows enactment by Pub. L. 96-359 on 1938-06-25.
all 0 arguments · sorted by: best
no arguments yet — make the first case